Cesar Marin joins the Psychedelic Scene Podcast to discuss microdosing after 50, life transitions, intention, integration, and responsible exploration.
Features
- Jill Sitnick
- No Comments
What happens when psychedelic therapy gets approved? Kimberly Chew explains FDA rules, costs, insurance, safety and access.
- Jill Sitnick
- No Comments
Paije West explores the differences between iboga and ibogaine, what really happens in ceremony, why medical screening matters, and the importance of honoring Bwiti traditions.
- raRÉ (The Psychedelic Biologist)
- No Comments
A biologist and brain aneurysm survivor recounts open-brain surgery, recovery, and a deeply personal journey with psilocybin, trauma, and renewal.
- Jill Sitnick
- 2 Comments
Discover how AI is transforming psychedelic integration by helping practitioners provide personalized support between sessions without replacing care.
- Scott B. Montgomery
- No Comments
Lee Conklin is one of psychedelic art's most underappreciated visionaries. Explore his groundbreaking Fillmore posters, the iconic Santana album cover, and the intricate masterpieces that cement his legacy as a true architect of psychedelic art.
- Jill Sitnick
- No Comments
John Gilchrist of Therapsil explains how psilocybin therapy is helping end-of-life patients ease anxiety, find meaning, and embrace acceptance.
- Lindsay Kent
- No Comments
In 1970, Playboy gathered William S. Burroughs, Ram Dass, Alan Watts, Harry Anslinger and others for a debate that foreshadowed today's drug policy discussions.
- Jill Sitnick
- No Comments
Christian Rasmussen explains what people get wrong about Amanita muscaria, its reported effects, and key safety considerations.